Vaxart, Inc. ( VXRT) - Key Metrics
VXRT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.45 | $0.24 | $0.13 | $0.13 |
| 2025Q3 | $0.32 | -$0.04 | $0.01 | $0.01 |
| 2025Q2 | $0.17 | -$0.07 | -$0.07 | -$0.07 |
| 2025Q1 | $0.09 | -$0.07 | -$0.04 | -$0.04 |
VXRT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 0.37 |
| 2025Q3 | ? | -2.53 |
| 2025Q2 | ? | -1.72 |
| 2025Q1 | ? | -1.49 |
VXRT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -1.70% | ? |
| 2025Q4 | 38.04% | ? |
| 2025Q3 | 3.01% | ? |
| 2025Q2 | -15.35% | ? |
| 2025Q1 | -10.49% | ? |
VXRT
Price: $0.60
52 week price:
Earnings Per Share: 0.16 USD
P/E Ratio: 4.31
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Ebitda: -2.9 millionMarket Capitalization: 167.0 million